Assessing How the Viscosity of Submucosal Gel Injections Helps With Endoscopic Mucosal Resections



Status:Recruiting
Conditions:Colorectal Cancer, Cancer, Cancer, Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:18 - 65
Updated:11/17/2018
Start Date:August 2014
End Date:May 2019
Contact:Danny A Sherwinter, MD
Email:dsherwinter@maimonidesmed.org
Phone:7182837952

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria
This is a study to determine how the viscosity (thickness) of an FDA approved gel affects the
ease in which endoscopic mucosal resections (EMR) can be performed.

This is a study to determine how the viscosity (thickness) of an FDA approved gel made by
Cook medical affects the ease in which endoscopic mucosal resections (EMR) - a type of
endoscopic surgery performed for localised cancer - can be performed when the gel is injected
submucosally. The lifting characteristics of the gel will be assessed by height and diameter
and ease with which the subsequent EMR dissection can be performed. These characteristics
would be assessed on excised human stomachs and colon, which are harvested during routine
sleeve gastrectomy surgeries or colectomies, in an ex-vivo manner.

Inclusion Criteria:

- Pts undergoing sleeve gastrectomy

- Pts undergoing colectomy

Exclusion Criteria:

- Unable to give or understand consent

- All of the excised tissue will be needed for diagnostic purposes
We found this trial at
1
site
Maimonides Medical Center
4802 10th Ave
Brooklyn, New York 11219
(718) 283-6000
Phone: 718-283-7952
Maimonides Medical Center At 103 years old, Maimonides Medical Center remains a vital and thriving...
?
mi
from
Brooklyn, NY
Click here to add this to my saved trials